CN Stock MarketDetailed Quotes
002551 Shenzhen Glory Medical
- 2.57
- +0.05+1.98%
Market Closed Sep 13 15:00 CST
2.17BMarket Cap-14855P/E (TTM)
2.63High2.49Low307.83KlotVolume2.52Open2.52Pre Close78.84MTurnover5.04%Turnover RatioLossP/E (Static)844.82MShares4.4752wk High0.83P/B1.57BFloat Cap2.1152wk Low2.77Limit Up610.39MShs Float34.20Historical High2.27Limit Down5.56%Amplitude2.11Historical Low--Dividend TTM2.56Avg Price150.97KlotAsk--Div YieldTTM100Lot Size154.19KlotBid
Shenzhen Glory Medical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -8.18%554.43M | 34.29%358.74M | -22.17%1.2B | -29.90%783.13M | -12.55%603.83M | -22.44%267.13M | -21.17%1.54B | -25.20%1.12B | -30.59%690.5M | -34.25%344.44M |
| Refunds of taxes and levies | -1.43%23.14M | 5.02%11.12M | -33.13%45.62M | -51.13%34.81M | -51.18%23.47M | 0.79%10.58M | 70.59%68.22M | 85.77%71.23M | 75.31%48.08M | 104.54%10.5M |
| Cash received relating to other operating activities | -49.85%15.95M | -31.55%8.7M | 94.70%76.9M | 18.11%65.73M | -19.16%31.81M | 126.22%12.71M | 8.97%39.5M | -29.56%55.65M | -21.44%39.34M | -82.46%5.62M |
| Cash inflows from operating activities | -9.95%593.52M | 30.35%378.56M | -19.82%1.32B | -28.96%883.67M | -15.27%659.11M | -19.45%290.43M | -18.82%1.65B | -22.77%1.24B | -27.45%777.92M | -35.73%360.56M |
| Goods services cash paid | -16.77%311.53M | 7.91%222.89M | -19.72%807.56M | -43.56%415.81M | -18.52%374.28M | -11.97%206.55M | -21.32%1.01B | -26.76%736.76M | -33.86%459.35M | -18.47%234.63M |
| Staff behalf paid | -9.83%123.33M | -12.80%61.31M | -5.98%280.08M | -9.42%199.02M | -0.42%136.77M | 3.27%70.31M | -11.53%297.88M | -10.76%219.72M | -11.39%137.35M | -14.32%68.08M |
| All taxes paid | -12.54%19.09M | -21.63%8.62M | 12.52%43.11M | -30.19%31.25M | -7.70%21.83M | 20.72%11.01M | 8.02%38.32M | -7.94%44.77M | -31.26%23.65M | -44.22%9.12M |
| Cash paid relating to other operating activities | -35.33%50.8M | -5.80%30.74M | -17.34%170.78M | -28.51%129.44M | -39.06%78.55M | 8.69%32.64M | 54.94%206.6M | -24.49%181.05M | -1.11%128.9M | -70.07%30.03M |
| Cash outflows from operating activities | -17.45%504.75M | 0.95%323.56M | -15.96%1.3B | -34.41%775.53M | -18.39%611.43M | -6.24%320.51M | -13.19%1.55B | -23.25%1.18B | -26.13%749.25M | -29.35%341.85M |
| Net cash flows from operating activities | 86.18%88.77M | 282.82%54.99M | -81.72%17.63M | 75.35%108.14M | 66.29%47.68M | -260.79%-30.08M | -60.24%96.45M | -12.13%61.67M | -50.53%28.67M | -75.74%18.71M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 0.26%615.59M | -5.19%329M | 65.78%1.21B | 35.10%905.5M | 8.63%614M | 6.73%347M | -32.11%732.63M | -9.97%670.25M | 12.49%565.25M | 225.11%325.11M |
| Cash received from returns on investments | -70.13%2.66M | -59.53%1.82M | ---- | 32.80%5.62M | 159.11%8.91M | -51.39%4.5M | ---- | -42.70%4.23M | -34.63%3.44M | 253.11%9.26M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | -98.37%190.6K | --7.5K | --1K | ---- | 2,941.85%11.72M | ---- | ---- | ---- |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | -27.90%1.08M | --1M | ---- | ---- | --1.5M | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | --5M | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | -0.75%618.25M | -7.20%330.82M | 63.01%1.22B | 35.23%912.13M | 9.54%622.91M | 6.62%356.5M | -31.42%745.85M | -10.30%674.48M | 12.00%568.68M | 225.82%334.37M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -18.64%12.33M | -17.93%5.98M | -26.58%42.07M | -47.26%20.25M | -51.67%15.15M | -50.21%7.29M | -86.67%57.3M | -45.69%38.39M | -46.58%31.35M | -66.27%14.64M |
| Cash paid to acquire investments | 15.30%627.21M | -12.56%249.21M | 27.10%1.1B | -3.47%774M | -6.98%544M | 3.64%285M | -29.12%865.39M | -10.61%801.8M | -10.99%584.8M | -24.86%275M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --150K | --150K | --150K | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 14.35%639.54M | -12.74%255.19M | 23.76%1.14B | -5.45%794.4M | -9.23%559.3M | 0.97%292.44M | -44.11%922.69M | -13.18%840.19M | -13.91%616.15M | -29.43%289.64M |
| Net cash flows from investing activities | -133.47%-21.29M | 18.05%75.63M | 141.77%73.87M | 171.05%117.73M | 233.99%63.61M | 43.23%64.06M | 68.61%-176.85M | 23.22%-165.71M | 77.17%-47.47M | 114.53%44.73M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | --187.39K | ---- | ---- | ---- | ---- |
| Cash from borrowing | ---- | ---- | ---- | ---- | ---- | ---- | -81.30%27.84M | -68.76%39.08M | -71.17%36.04M | -80.00%24.84M |
| Cash received relating to other financing activities | 223.48%30.87M | --30.82M | -13.20%40.93M | -70.54%10.26M | -38.97%9.54M | ---- | 19.20%47.15M | 42.19%34.84M | -19.75%15.64M | -25.08%5.97M |
| Cash inflows from financing activities | 223.48%30.87M | 16,347.39%30.82M | -45.42%40.93M | -86.12%10.26M | -81.53%9.54M | -99.39%187.39K | -74.78%74.99M | -71.50%73.92M | -64.23%51.68M | -76.69%30.81M |
| Borrowing repayment | 48.46%45.33M | -20.52%890K | -53.32%41.46M | 32.69%72.52M | 18.08%30.53M | -95.48%1.12M | -64.24%88.82M | -68.56%54.66M | -84.66%25.86M | -80.45%24.76M |
| Dividend interest payment | 0.44%6.13M | -27.34%4.48M | -64.11%58.85M | -94.03%7.45M | -78.34%6.1M | -45.98%6.17M | 441.28%163.95M | 293.48%124.78M | -9.40%28.16M | -53.93%11.42M |
| Cash payments relating to other financing activities | 21.96%3.47M | -60.22%61.42K | 44.42%19.23M | 173.35%20.53M | -60.26%2.85M | -95.73%154.41K | 28.21%13.32M | 14.70%7.51M | 30.12%7.17M | 19.73%3.62M |
| Cash outflows from financing activities | 39.13%54.93M | -27.00%5.43M | -55.07%119.54M | -46.24%100.51M | -35.47%39.48M | -81.30%7.44M | -7.95%266.09M | -11.86%186.94M | -70.18%61.18M | -74.24%39.79M |
| Net cash flows from financing activities | 19.64%-24.06M | 449.99%25.39M | 58.86%-78.61M | 20.15%-90.24M | -215.05%-29.94M | 19.18%-7.25M | -2,396.99%-191.09M | -339.09%-113.02M | 84.33%-9.5M | 59.73%-8.98M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -85.13%1.56M | -96.31%611.28K | 18.11%7.15M | -62.78%10.54M | -40.57%10.5M | 637.46%16.56M | 27.85%6.05M | 519.25%28.33M | 415.33%17.67M | -348.36%-3.08M |
| Net increase in cash and cash equivalents | -51.02%44.99M | 261.80%156.62M | 107.55%20.04M | 177.45%146.17M | 963.88%91.85M | -15.75%43.29M | 13.75%-265.44M | -79.55%-188.74M | 95.08%-10.63M | 120.41%51.38M |
| Add:Begin period cash and cash equivalents | 5.18%407.25M | 5.18%407.25M | -40.67%387.2M | -40.67%387.2M | -40.67%387.2M | -40.67%387.2M | -32.04%652.64M | -32.04%652.64M | -32.04%652.64M | -32.04%652.64M |
| End period cash equivalent | -5.60%452.24M | 30.98%563.86M | 5.18%407.25M | 14.98%533.38M | -25.38%479.05M | -38.85%430.49M | -40.67%387.2M | -45.76%463.9M | -13.72%642.01M | -0.65%704.02M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- |
| Auditor | -- | -- | Asia Pacific (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Asia Pacific (Group) Accounting Firm (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data